Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes

BACKGROUND: In studying the therapeutic evidence of innovative drug treatments, increasing attention is being devoted to differentiating between results that indicate no significant differences among the treatments under examination (“no proof of difference”) and results that demonstrate the therape...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Messori, Andrea, Fadda, Valeria, Maratea, Dario, Trippoli, Sabrina, Marinai, Claudio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Healthcare 2014
Onderwerpen:
Brief Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4065299/
https://ncbi.nlm.nih.gov/pubmed/24793219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-014-0066-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items